Medical research

Photopharmacology: Optical control of insulin secretion

Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have chemically modified an anti-diabetic agent so as to make its action dependent on light. The resulting prototype compound, termed JB253, induces release of ...

Diseases, Conditions, Syndromes

Advancing understanding of treatment through clinical trials

Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease.

page 1 from 2